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 1 
Abstract 2 
Short antimicrobial peptides represent an alternative to fight pathogen 3 
infections. PAF26 is a hexapeptide identified previously by a combinatorial approach 4 
against the fungus Penicillium digitatum and shows antimicrobial properties towards 5 
certain phytopathogenic fungi. In this work, PAF26 was used as lead compound and its 6 
properties were compared with two series of derivates, obtained by either systematic 7 
alanine substitution or N-terminal amino acid addition. The alanine scan approach 8 
underlined the optimized sequence of PAF26 in terms of potency and permeation 9 
capability, and also the higher contribution of the cationic residues to these properties. 10 
The N-terminal addition of amino acids resulted in new heptapeptides with variations in 11 
their antimicrobial characteristics, and very low cytolysis to human red blood cells. 12 
Positive (Arg or Lys) and aromatic (Phe or Trp) residue addition increased broad 13 
spectrum activity of PAF26. Noteworthy, addition of selected residues had specific 14 
effects on the properties of derivatives of PAF26. 15 
 16 
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Introduction 1 
 2 
Antimicrobial peptides (AMP) are important components of an evolutionarily 3 
ancient mechanism of immunity, found in a wide range of organisms [1]. AMP differ in 4 
length, sequence and structure, but generally are amphipathic and a great number have 5 
positive charge and are refereed as cationic antimicrobial peptides (CAMP). In many 6 
examples, these peptides are effective against microorganisms resistant to antibiotics or 7 
fungicides. In addition, AMP are unlikely to cause rapid emergence of resistance [2]. 8 
These facts and their short length, fast and efficient action against microbes and low 9 
toxicity to mammal cells have made them potential candidates as peptide drugs. 10 
Rational design of AMP is an attractive approach to the improvement of 11 
antimicrobial properties. Agriculture could also greatly benefit from this emerging 12 
research area, with the identification, design and selection of peptides targeted to 13 
specific plant protection problems [3-6]. Soluble combinatorial libraries (SCL) 14 
represent an extensive source of molecular diversity for the de novo identification of 15 
lead AMP with new properties [7]. SCL have been used to identify novel peptides 16 
towards phytopathogenic fungi such as 66-10 hexapeptide (Ac-frlkfh-NH2) [8] and its 17 
derivative heptapeptide 77-3 (Ac-frlkfhf-NH2), which has activity against fungal strains 18 
of Fusarium sambucinum that are resistant to the fungicide thiabendazole (TBZ) [5]. In 19 
a previous work, we have used a synthetic D-hexapeptide library in a positional 20 
scanning format to identify AMP against selected phytopathogenic fungi that cause 21 
postharvest decay in fruits, such as Penicillium digitatum [6]. One of these peptides is 22 
PAF26 (Table 1), which showed strong activity against certain filamentous fungi and 23 
lower toxicity to Escherichia coli and Saccharomyces cerevisiae [6]. 24 
PAF26 is a tryptophan-rich CAMP with sequence similarities to other AMP [9-25 
13]. It shares some properties with similar peptides, as absence of hemolytic activity 26 
[12,14]. PAF26 is active against strains resistant to fungicides and performed better than 27 
TBZ in experimental fruit decay tests [15]. Additionally, we have also demonstrated 28 
that PAF26 belongs to the class of AMP endowed with cell-penetrating properties 29 
[16,17], being capable to specifically interact with and locate inside target fungal cells 30 
[14]. PAF26 and similar peptides synthesized with either D- or L-enantiomers do not 31 
differ substantially in antimicrobial potency [9,11,14], which makes biotechnological 32 
production feasible.  33 
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In this work, we have used PAF26 as a lead in an optimization strategy to design 1 
two sets of peptides with single residue variations. The purpose was to analyze the 2 
effect of such variations in the antimicrobial properties of the resulting peptides. First, 3 
alanine substitution analogues addressed the influence of each residue on PAF26 4 
antimicrobial properties. Secondly, we designed and compared novel heptapeptides 5 
obtained by addition of different N-terminal residues to PAF26 in terms of (i) spectrum 6 
of activity, (ii) specificity, (iii) microbicidal properties, and (iv) cytolysis of human red 7 
blood cells.  8 
 9 
 10 
Materials and methods 11 
 12 
Microorganisms. We used microorganisms that included fungal isolates of 13 
agricultural relevance (three distinct species of Penicillium, and Alternaria sp., 14 
F. oxysporum, B. cinerea and M. grisea) as well as fungal (A. nidulans), yeast 15 
(S. cerevisiae) and bacterial (E. coli and B. subtillis) model strains (see Supplemental 16 
Table 4). Fungi were cultured on potato dextrose agar (PDA) (Difco-BD Diagnostics, 17 
Sparks, MD) plates at 24 ºC with the exception of M. grisea, which was maintained on 18 
rice flour medium. Conidia were collected and adjusted to the appropriate 19 
concentration. S. cerevisiae was grown in YPD (1% yeast extract, 1.5% peptone, 2% 20 
dextrose) at 30 ºC and bacteria were grown in Luria-Bertani (LB) medium at 37 ºC.  21 
 22 
Peptides. Peptides used in this work (Table 1 and Supplemental Table 3) were 23 
purchased at >90% purity (GenScript Corporation, Piscataway, NJ). Peptides were 24 
acetylated at the N-terminus (Ac) and amidated at the C-terminus (NH2). Stocks were 25 
prepared at 1 mM in 5 mM 3-(N-morpholino)-propanesulfonic acid pH 7 buffer and 26 
stored at -20 ºC. Peptide concentrations were determined by absorbance at 280 nm.  27 
 28 
Growth inhibition assays. The antimicrobial activities of the peptides were 29 
determined using a microtiter plate assay [6,18]. Growth was quantified as optical 30 
density (OD) at 492 nm. Potato dextrose broth (PDB) (Difco-BD Diagnostics) diluted 31 
one twentieth (5% PDB) was used as growth medium for fungi, and YPD diluted one 32 
tenth (10% YPD) for yeast, in both cases containing 0.003% (w/v) chloramphenicol. In 33 
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antibacterial assays, the medium was LB diluted one tenth (10% LB). Three replicates 1 
were prepared for each treatment. 2 
The minimum inhibitory concentration (MIC) of a peptide for a given 3 
microorganism was the lowest peptide concentration that showed no growth at the end 4 
of the experiment. The IC50 of a peptide was the concentration required to obtain 50% 5 
inhibition of growth, and the value in each experiment was estimated by adjustment of 6 
the experimental data (SigmaPlot v 8.02, SPSS Inc., Chicago, IL). Statistical analyses 7 
were carried out with the software package StatGraphics Plus 4.0 (Manugistics Inc., 8 
Rockville, MD).  9 
 10 
Membrane permeation assays. Membrane permeation was determined with the 11 
probe Sytox Green (SG) (Molecular Probes-Invitrogen Corp., Carlsbad, CA) and 12 
fluorometric measurement with a microplate reader (Fluoroskan Ascent FL, 13 
Labsystems, Finland) at an excitation of 485 nm and emission of 538 nm wavelengths 14 
[14]. Three replicates were prepared for each treatment. The FC50 of a peptide was 15 
defined as the concentration inducing 50% of the maximum fluorescence emission, and 16 
the values were calculated by adjustment of the experimental data as above. 17 
 18 
Fungicidal and bactericidal activity assays. Assessment of peptide microbicidal 19 
activity was conducted as follows. In the case of P. digitatum, 2.5 x 104 conidia/ml were 20 
incubated with peptides in 5% PDB at 24 ºC. After 1 day of incubation, 50 µl samples 21 
were spread onto peptide-free PDA plates to monitor colony forming units. S. cerevisiae 22 
and E.  coli (5.0 x 105 CFU/ml) were incubated for 1 day with peptides in either 10% 23 
YPD at 30 ºC or 10% LB at 37 ºC, respectively, and 2.5 µl drops of samples were 24 
placed onto YPD or LB peptide-free plates. The lethal concentration (LC) of a peptide 25 
was defined as the lowest peptide concentration at which no growth or <1% of CFU was 26 
recovered after peptide treatment. 27 
 28 
Hemolytic activity assay. The cytolytic activity of the peptides on human red 29 
blood cells was determined as release of hemoglobin monitored by absorbance at 30 
415 nm [14]. Peptides were used at final concentrations of 1, 10 or 100 µM. Zero 31 
percent hemolysis and 100% hemolysis controls were determined in PBS and 0.1% 32 
Triton X-100, respectively. 33 
 34 
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 1 
Results and discussion 2 
 3 
Antimicrobial properties of a series of alanine substitution analogues of PAF26. 4 
We designed a set of six Ala substitution analogues of the cationic tryptophan-5 
rich hexapeptide PAF26 (PAF26.r1a to PAF26.w6a, Table 1 and Supplemental 6 
Table 3). Distinct antimicrobial properties were determined and the results are 7 
summarized as IC50, MIC and LC towards P. digitatum (Table 2). We observed lower 8 
activity for all the analogues, although the decrease was higher in the peptides with 9 
substitution of the positively charged residues (PAF26.r1a, .k2a and .k3a), which 10 
approximately four-fold higher MIC and LC, and higher significant differences in the 11 
IC50.  12 
We also used an assay based on the uptake of SG to quantify the permeation of 13 
P. digitatum mycelium promoted by the analogues. SG assays have been used to 14 
establish a link between antimicrobial activity of AMP and cell permeation [5,19]. 15 
Previously, we demonstrated that incubation of fungal hyphae with PAF26 resulted in 16 
uptake and increase in the fluorescence of SG [14]. 17 
We have quantified and compared the permeation capability of the Ala 18 
analogues with PAF26, by determining permeation dose-response curves in conjunction 19 
with inhibition curves (Fig. 1). Data allowed the calculation of FC50 as an estimate of 20 
the permeation capability of peptides (Table 2). In the case of PAF26 and the 21 
PAF26.f5a analog, the permeation curve paralleled that of growth inhibition (Fig. 1A 22 
and C), and both peptides had IC50 and FC50 values not significantly different (Table 2). 23 
Regarding the other five analogs, a noticeable result was the slight but consistently 24 
reproduced higher peptide concentrations needed to achieve 50% permeation (FC50) 25 
than 50% inhibition (IC50). This distinct effect could be visualized by plotting the 26 
relative activities for the six analogs as compared to PAF26 (Fig. 2). All the analogous 27 
except PAF26.f5a had losses of permeation capability (white bars) higher than losses of 28 
inhibition activity (black bars) (Fig. 2). Such differences among peptides are 29 
exemplified in a representative experiment (Fig. 1). PAF26.f5a initiates permeation and 30 
reaches maximum at concentrations similar to PAF26, in a curve that mirrors the 31 
inhibition response, while PAF26.r1a has a permeation curve shifted to higher peptide 32 
concentrations as compared to growth inhibition.  33 
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This differential effect of each Ala substitution in either the antimicrobial or the 1 
permeation properties dissociate to some extent growth inhibition from permeation 2 
among the different peptides, thus suggesting that PAF26 antimicrobial action is not 3 
solely based on its ability to permeate target cells. This has been previously proposed 4 
for other AMP [1,2,9,16,17], and also explored in the case of PAF26, for which it was 5 
shown microscopically that produces growth alterations of mycelium in areas that are 6 
not permeabilized [14]. Moreover, PAF26 is internalized by P. digitatum hyphae at very 7 
low sub-inhibitory concentrations (i.e., 300 nM) that have no detectable effect on 8 
growth, morphology or permeation [14]. 9 
Therefore, our Ala scanning approach showed that all the amino acid residues in 10 
PAF26 contribute to some extent to its antifungal or permeation activities and that none 11 
of them is dispensable for its properties towards P. digitatum. However, differences 12 
among the analogs were observed. PAF26 has an amphipathic arrangement with three 13 
N-terminal cationic residues followed by three aromatic and hydrophobic residues at the 14 
C-terminus. Distinct independent parameters (Table 2 and Fig. 2) indicated that the 15 
antimicrobial potency and permeation properties were more affected by substitutions of 16 
the cationic rather than of the aromatic amino acids. The activity of CAMP, including 17 
those rich in Trp as PAF26, is dependent on the ionic environment [10,13,20], 18 
indicating that the initial interaction with microbes is electrostatic. In fact, confocal 19 
microscope observations have shown that indolicidin and PAF26 primarily interact with 20 
surfaces of hyphae [13,14]. The results of the Ala scan approach confirm the importance 21 
of such electrostatic interaction for antimicrobial activity and permeation. 22 
Our data indicate that the two Trp residues follow in relevance to the cationic 23 
ones (Table 2). It has been reported that PAF26 interacts in vitro with membrane 24 
mimetics and that substitution of Trp-4 for Pro decreases this interaction and 25 
concomitantly also biological activity [21]. Finally, Phe-5 was found to be the least 26 
significant residue since its replacement produced a peptide with modest differences as 27 
compared to PAF26 and in fact its dose response curves were quite similar to that of 28 
PAF26 (Fig. 1). 29 
 30 
Distinct activity profiles of heptapeptides derived from PAF26 by amino acid addition. 31 
Improvement in PAF26 antimicrobial potency and/or specificity could be 32 
achieved by means of replacement for, or addition of, specific amino acids. We have 33 
explored such scenario by addition of selected N-terminal residues and screening of the 34 
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resulting set of heptapeptides. Similar approaches have been used to improve other lead 1 
AMP [5,9]. Amino acids highly represented in AMP databases [22] were chosen: the 2 
positively charged residues Arg, Lys and His, the aromatic residues Trp, Phe and Tyr, 3 
the aliphatic residues Leu and Ala, and hydrophilic residues Thr and Gln (Table 1). The 4 
ten different resulting heptapeptides had 3-4 positive net charges at neutral pH and 5 
distinct hydropathic indexes that indicate a hydrophilic character (Supplemental 6 
Table 3). 7 
An evaluation of antimicrobial potency and specificity was carried out against a 8 
panel of selected microorganisms that include fungi of agronomic relevance as well as 9 
the model filamentous fungus A. nidulans, the yeast S. cerevisiae, the Gram negative 10 
bacteria E. coli and the Gram positive B. subtillis, in order to assay overall activity, 11 
specificity, and bioactivity against reluctant fungi. The parameters IC50 and MIC were 12 
calculated (Supplemental Table 4). The previously described hexapeptide PAF34, 13 
which differ from PAF26 in two amino acid residues (Table 1), was introduced as a 14 
control of antimicrobial peptide with lower specificity than PAF26 [6].  15 
Distinct inhibitory profiles of the heptapeptides were found (Supplemental 16 
Table 4). Considering the microorganisms, P. digitatum was the most sensitive to AMP 17 
based on the PAF26 lead, as expected given that this peptide was found in a 18 
combinatorial screen against this fungus. On the other hand, the least sensitive 19 
microorganisms were the phytopathogenic fungus M. grisea, the yeast S. cerevisiae and 20 
the bacteria E. coli. The non-filamentous microorganism that has the susceptibility 21 
pattern more similar to the filamentous fungi was the Gram positive bacterium 22 
B. subtilis.  23 
Taking into account the different peptides, the generally most active ones were 24 
PAF38 (Arg) and PAF39 (Lys), a result in agreement with the above demonstrated 25 
importance of cationic N-terminal residues in the activity of PAF26. However, our 26 
study found no clear correlation between the antimicrobial potency/specificity and the 27 
molecular weight, net charge, or hydrophilicity character of the peptides (Supplemental 28 
Table 4), suggesting that more complex interactions between the amino acid residues 29 
determine the antimicrobial properties. In other AMP, it has been shown that 30 
appropriate position/clustering of residues are determinant for activity and selectivity 31 
[12]. 32 
It was remarkable the higher activity against the economically important 33 
M. grisea of PAF41 (Phe) and PAF42 (Trp), but not of PAF38 and PAF39. In the case 34 
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of B. cinerea and F. oxysporum a modest two-fold increase in the MIC was found in 1 
PAF40 (His) and PAF38, respectively, as compared to PAF26. 2 
In most of the peptides the increase in antifungal activity correlates with an even 3 
higher increase in activity against the bacteria and yeast (Supplemental Table 4). In fact, 4 
the addition of cationic (PAF38, PAF39) or aromatic hydrophobic (PAF41, PAF42) 5 
residues showed a higher increase in antibacterial than in antifungal properties. 6 
There were peptides that showed an improvement in the IC50 but a deleterious 7 
effect on the MIC, for instance in the case of PAF45 (Thr), PAF46 (Gln) or PAF47 8 
(Ala) against P. digitatum, emphasizing the existence of differently shaped dose-9 
response curves and the need for considering different parameters when characterizing 10 
antimicrobials [23].  11 
 12 
Microbicidal assays of heptapeptides derived from PAF26. 13 
The killing capacity of peptides to conidia of P. digitatum, or cells of E. coli and 14 
S. cerevisiae was evaluated (Fig. 3). It has been previously shown that inhibitory and 15 
fungicidal properties against P. digitatum are not linked in selected AMP, as 16 
lactoferricin-derived peptides and melittin [14,18]. This experiment confirmed the 17 
reverse microbicidal properties of PAF26 and PAF34 (Fig. 3A). These two peptides 18 
have distinct activity profiles: PAF26 is more microbicidal than PAF34 to P. digitatum, 19 
while less to S. cerevisiae and E. coli. 20 
Microbicidal data confirmed and extended the growth inhibition results 21 
described above. The cationic derivatives PAF38 and PAF39 showed a two-fold 22 
improvement of fungicidal activity against P. digitatum but also killed S. cerevisiae and 23 
E. coli more efficiently (Fig. 3B).  24 
PAF40 has activity against P. digitatum and S. cerevisiae similar to the 25 
sequence-related PAF38, PAF39, PAF41 and PAF42, but a four-fold reduction in 26 
killing capacity to E. coli (Supplemental Table 4 and Fig. 3B). On the contrary, some of 27 
the peptides as PAF43 (Tyr) showed an increase in activity against bacteria while had 28 
activity against several fungi similar to PAF26 (Supplemental Table 4 and Fig. 3B). In 29 
fact, PAF40 and PAF43 showed reversal microbicidal properties towards S. cerevisiae 30 
and E. coli (Fig. 3B). 31 
Also noticeable was the loss of fungicidal activity against conidia of P. 32 
digitatum of some peptides as PAF46 (Fig. 3B). We have reported that peptides derived 33 
from the antimicrobial motif of bovine Lactoferricin [10], which shown sequence 34 
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similarities with PAF26 and also contain a Gln residue, have IC50 values very similar to 1 
PAF26 but a much lower fungicidal activity to P. digitatum [18]. This finding will 2 
guide future experiments to test whether Gln residues negatively impact fungicidal 3 
properties of CAMP while maintaining growth inhibition, and thus whether 4 
determinants of CAMP fungiestatic and fungicidal properties differ. 5 
Overall, our results indicate that some of the modifications resulted in broader 6 
antimicrobial activity, and therefore would be undesirable whenever filamentous fungi 7 
are the specific target of the antimicrobial approach. Also, data provide information to 8 
the development of novel peptides with broader activities. The detrimental loss of 9 
antifungal properties of some heptapeptides also demonstrates that the presence of the 10 
PAF26 sequence by itself does not guarantee high inhibitory activity, confirming that a 11 
specific arrangement of a peptide sequence and interactions between residues are also 12 
important for the properties of AMP [12,24]. 13 
 14 
Evaluation of hemolytic activity of heptapeptides derived from PAF26. 15 
An evaluation of toxicity was performed by conducting hemolytic assays on 16 
human red blood cells at different peptide concentrations (1, 10 and 100 µM). All 17 
except one of the PAF26-derived peptides described in this work exhibited no 18 
hemolysis even at 100 µM (i.e., below the detection limit, which in our assay is 0.3% of 19 
the hemolysis of the control). The only peptide showing marginal toxicity was PAF42 20 
(Trp) that produced 0.6% hemolysis at 100 µM. The well known toxic peptide Melittin 21 
(used as control) was 100% hemolytic at 100 µM and 38% at 10 µM. Data indicate that 22 
PAF heptapeptides are at least 1000 times less cytolytic to red blood cells than Melittin. 23 
It has been reported that PAF26 and Melittin are similarly active against P. digitatum, 24 
being Melittin more toxic to bacteria [6]. 25 
 26 
Conclusion 27 
 28 
We have generated a series of peptides derived from PAF26, with different 29 
profiles of antimicrobial properties and negligible hemolysis. They are of interest in the 30 
development of novel AMP, adding to the catalog of compounds with potential 31 
application in agriculture and biomedicine. Selection of the most suitable peptide would 32 
depend on the importance for each particular use of potency and/or specificity. 33 
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Figure legends 1 
 2 
Fig. 1 3 
Dose-response curves of inhibition (black circles) and permeation (white triangles) 4 
activity of peptides PAF26 (A), PAF26.r1a (B) and PAF26.f5a (C) on P. digitatum. 5 
Data shown are the mean values ± SD of either OD (492 nm) or (FI) (538 nm).  6 
 7 
Fig. 2 8 
Relative antimicrobial and permeation activity of the Ala substitution analogs as 9 
compared to the parental peptide PAF26. Bars represent the relative IC50 as measure of 10 
growth inhibition (black bars), FC50 as measure of permeation (white bars), and LC as 11 
measure of fungicidal activity to conidia (stripped bars). Relative values were calculated 12 
taking the corresponding parameter of PAF26 as reference. 13 
 14 
Fig. 3 15 
Assessment of microbicidal activity of peptides against P. digitatum (left), S. cerevisiae 16 
(middle) and E. coli (right). Microorganism samples, either conidia (P. digitatum) or 17 
CFU (S. cerevisiae and E. coli), were treated with selected peptide concentrations (top) 18 
for 1 day, and spread (for the fungus) or applied as droplets (for the yeast and bacteria) 19 
onto peptide-free plates. Representative photographs are shown for (A) the previously 20 
described PAF26 and PAF34, and (B) for the novel heptapeptides described here 21 
(PAF38 to PAF47). 22 
 23 
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Table 1 
Amino acid sequences of peptides. 
 
Peptide Sequence a 
PAF26  Ac-rkkwfw-NH2 
PAF34  Ac-rkwlfw-NH2 
PAF26.r1a  Ac-akkwfw-NH2 
PAF26.k2a  Ac-rakwfw-NH2 
PAF26.k3a  Ac-rkawfw-NH2 
PAF26.w4a  Ac-rkkafw-NH2 
PAF26.f5a  Ac-rkkwaw-NH2 
PAF26.w6a  Ac-rkkwfa-NH2 
PAF38 Ac-rrkkwfw-NH2 
PAF39 Ac-krkkwfw-NH2 
PAF40 Ac-hrkkwfw-NH2 
PAF41 Ac-frkkwfw-NH2 
PAF42 Ac-wrkkwfw-NH2 
PAF43 Ac-yrkkwfw-NH2 
PAF44 Ac-lrkkwfw-NH2 
PAF45 Ac-trkkwfw-NH2 
PAF46 Ac-qrkkwfw-NH2 
PAF47 Ac-arkkwfw-NH2 
 
a The D-amino acids are shown in lower case. 
Residues distinct from PAF26 are in bold. 
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Table 2 
Antimicrobial properties of PAF26 analogues towards P. digitatum. 
 
Peptide IC50 (µM) a,b MIC (µM) LC (µM) FC50 (µM) a,b 
PAF26 2.2 ± 0.3 (a) 4 16   1.7 ± 0.2 (a) 
PAF26.r1a 6.3 ± 1.1 (c) 16 >64 11.5 ± 1.1 (c) 
PAF26.k2a 5.6 ± 1.5 (c) 16 64   7.7 ± 2.4 (b) 
PAF26.k3a 6.6 ± 2.1 (c) 16 >64   7.9 ± 3.0 (bc) 
PAF26.w4a 3.2 ± 0.7 (ab) 8 32   6.3 ± 1.4 (b) 
PAF26.f5a 2.8 ± 0.6 (ab) 8 32   2.0 ± 0.4 (a) 
PAF26.w6a 3.7 ± 0.5 (b) 16 32   5.7 ± 0.6 (b) 
a  Mean value ± standard deviation, calculated from independent experiments.  
b  Values with the same letter do not differ at 95% confidence level (Fisher's LSD 
procedure). 
 
Peptide (µM)
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Supplemental Table 3 
Amino acid sequences and properties of peptides used in this study. 
 
Peptide Sequence a MW Net charge b GRAVY c Source 
      
PAF26  Ac-rkkwfw-NH2 991.2 3+ -1.883 [1] 
PAF34  Ac-rkwlfw-NH2 976.2 2+ -0.600 [1] 
PAF26.r1a  Ac-akkwfw-NH2 906.1 2+ -0.833 This study 
PAF26.k2a  Ac-rakwfw-NH2 934.1 2+ -0.933 This study 
PAF26.k3a  Ac-rkawfw-NH2 934.1 2+ -0.933 This study 
PAF26.w4a  Ac-rkkafw-NH2 876.1 3+ -1.433 This study 
PAF26.f5a  Ac-rkkwaw-NH2 915.1 3+ -2.050 This study 
PAF26.w6a  Ac-rkkwfa-NH2 876.1 3+ -1.433 This study 
PAF38 Ac-rrkkwfw-NH2 1147.4 4+ -2.257 This study 
PAF39 Ac-krkkwfw-NH2 1119.4 4+ -2.171 This study 
PAF40 Ac-hrkkwfw-NH2 1128.3 3.1+ -2.071 This study 
PAF41 Ac-frkkwfw-NH2 1138.4 3+ -1.214 This study 
PAF42 Ac-wrkkwfw-NH2 1177.4 3+ -1.743 This study 
PAF43 Ac-yrkkwfw-NH2 1154.4 3+ -1.800 This study 
PAF44 Ac-lrkkwfw-NH2 1104.4 3+ -1.071 This study 
PAF45 Ac-trkkwfw-NH2 1092.3 3+ -1.714 This study 
PAF46 Ac-qrkkwfw-NH2 1119.3 3+ -2.114 This study 
PAF47 Ac-arkkwfw-NH2 1062.3 3+ -1.357 This study 
      
 
a The D-amino acids are shown in lower case. Residues distinct from PAF26 are in bold. 
b Estimated at pH = 7. 
c Peptide grand average of hydropathicity (GRAVY) index [2] was calculated using a web-based 
tool (http://www.expasy.ch/). 
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Supplemental Table 4 
Growth inhibitory activity of synthetic peptides against different microorganism. 
 
Peptide b 
Microorganism a 
PAF26 PAF34 PAF38 PAF39 PAF40 PAF41 PAF42 PAF43 PAF44 PAF45 PAF46 PAF47 
P. digitatum PHI-26  2.2 (4) 6.9 (8) 1.4 (4) 2.3 (4) 1.7 (4) 1.7 (4) 1.6 (4) 2.8 (8) 1.5 (4) 1.4 (8) 1.6 (8) 1.9 (8) 
P. italicum PHI-1 2.3 (4) 6.0 (8) 1.9 (4) 3.4 (8) 2.1 (4) 2.4 (4) 3.4 (4) 2.1 (4) 2.2 (4) 2.2 (4) 3.2 (8) 3.8 (8) 
P. expansum PHI-65 3.2 (8) 6.9 (16) 2.7 (8) 3.5 (8) 4.2 (8) 4.2 (8) 4.4 (8) 4.4 (8) 2.3 (8) 4.5 (8) 4.1 (8) 4.7 (8) 
Alternaria sp. PHI-44 4.6 (8) 8.1 (16) 2.4 (8) 4.5 (8) 7.0 (8) 5.1 (8) 5.1 (8) 6.8 (16) 6.9 (8) 5.5 (8) 7.0 (16) 5.7 (16) 
A. nidulans biA1 3.6 (8) 7.2 (8) 2.2 (4) 2.1 (4) 2.3 (4) 2.4 (8) 2.6 (8) 3.8 (8) 2.3 (4) 3.7 (8) 2.4 (4) 2.2 (4) 
B. cinerea #8  2.9 (8) 5.4 (16) 3.1 (8) 2.7 (8) 2.4 (4) 4.3 (8) 3.1 (8) 4.1 (8) 3.5 (8) 3.2 (8) 4.0 (8) 4.4 (8) 
F. oxysporum CECT2866  4.5 (8) 7.5 (16) 2.3 (4) 2.3 (8) 2.5 (8) 2.7 (8) 2.4 (8) 4.1 (8) 3.7 (8) 4.1 (8) 3.4 (8) 4.1 (8) 
M. grisea PR-9  (>32) c 9.4 (32) (>32) c (>32) c (>32) c 9.0 (16) 6.7 (16) (>32) c (>32) c (>32) c (>32) c (>32) c 
E. coli DH5α  20.4 (64) 15.5 (32) 4.5 (8) 6.7 (8) 12.7 (32) 4.5 (8) 5.1 (8) 8.7 (16) 14.4 (16) 17.1 (32) 22.2 (64) 17.3 (32) 
B. subtilis CECT498  4.0 (16) 5.6 (16) 2.0 (8) 2.6 (8) 4.1 (8) 2.1 (8) 1.1 (4) 2.5 (8) 2.5 (8) 4.3 (16) 4.8 (16) 5.4 (16) 
S. cerevisiae FY1679 15.9 (32) 13.4 (32) 9.0 (16) 8.1 (16) 9.2 (16) 10.5 (16) 16.6 (32) 17.6 (32) 15.5 (32) 13.0 (32) 12.9 (32) 20.1 (32) 
 
a For fungi, the assay mixture contained 2.5 x 104 conidia/ml and different peptide concentrations up to 32 µM (0.25, 0.5, 1, 2, 4, 8, 16 and 32 µM). For yeast and bacteria the assays 
contained 5.0 x 105 CFU/ml and different peptide concentrations up to 64 µM (2, 4, 8, 12, 16, 24, 32, 48 and 64 µM). 
b Data are shown as IC50 value, followed by MIC value in parenthesis, in µM units. IC50 is the mean value obtained from independent experiments. MIC is the minimum concentration 
that was completely inhibitory in all the experiments. 
c The symbol “>” indicates some, but not complete, inhibition of growth at the highest concentration used. In these cases, the IC50 was not calculated. 
 
